Form 4: Cytokinetics Director Receives Stock Grant
Insider Transaction (Form 4)
John T Henderson, a Director of Cytokinetics Inc, received 272 shares of common stock on July 15, 2026.
Summary
- Grant/award: acquired 272 Common Stock at $82.62 ($22,473) on July 15, 2026; holds 78,360 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
John T Henderson — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-15 | Grant/award | Common Stock | 272 | $83 | $22.5K | 78,360 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-15 | Grant/award (272 shares) |
Keywords
insider transaction, Form 4, CYTK, CYTOKINETICS INC, neutral, John T Henderson
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.